Cargando…

Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases

BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chong, Wang, Xiang-Yu, Zuo, Jie-Liang, Wang, Xue-Fu, Feng, Xiao-Wen, Zhang, Bo, Li, Yi-Tong, Yi, Chen-He, Zhang, Peng, Ma, Xiao-Chen, Chen, Zhen-Mei, Ma, Yue, Han, Jia-Hao, Tao, Bao-Rui, Zhang, Rui, Wang, Tian-Qi, Tong, Li, Gu, Wang, Wang, Si-Yu, Zheng, Xiao-Fei, Yuan, Wen-Kang, Kan, Zi-Jie, Fan, Jie, Hu, Xiang-Yang, Li, Jun, Zhang, Chao, Chen, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923349/
https://www.ncbi.nlm.nih.gov/pubmed/36759015
http://dx.doi.org/10.1136/jitc-2022-006425
_version_ 1784887719034355712
author Zhang, Chong
Wang, Xiang-Yu
Zuo, Jie-Liang
Wang, Xue-Fu
Feng, Xiao-Wen
Zhang, Bo
Li, Yi-Tong
Yi, Chen-He
Zhang, Peng
Ma, Xiao-Chen
Chen, Zhen-Mei
Ma, Yue
Han, Jia-Hao
Tao, Bao-Rui
Zhang, Rui
Wang, Tian-Qi
Tong, Li
Gu, Wang
Wang, Si-Yu
Zheng, Xiao-Fei
Yuan, Wen-Kang
Kan, Zi-Jie
Fan, Jie
Hu, Xiang-Yang
Li, Jun
Zhang, Chao
Chen, Jin-Hong
author_facet Zhang, Chong
Wang, Xiang-Yu
Zuo, Jie-Liang
Wang, Xue-Fu
Feng, Xiao-Wen
Zhang, Bo
Li, Yi-Tong
Yi, Chen-He
Zhang, Peng
Ma, Xiao-Chen
Chen, Zhen-Mei
Ma, Yue
Han, Jia-Hao
Tao, Bao-Rui
Zhang, Rui
Wang, Tian-Qi
Tong, Li
Gu, Wang
Wang, Si-Yu
Zheng, Xiao-Fei
Yuan, Wen-Kang
Kan, Zi-Jie
Fan, Jie
Hu, Xiang-Yang
Li, Jun
Zhang, Chao
Chen, Jin-Hong
author_sort Zhang, Chong
collection PubMed
description BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection from three cancer centers were included. The TLSs were categorized according to their anatomic subregions and quantified, and a TLS scoring system was established for intratumor region (T score) and peritumor region (P score). Differences in relapse-free survival (RFS) and overall survival (OS) between groups were determined. Multiplex immunohistochemical staining (mIHC) was used to determine the cellular composition of TLSs in 40 CRCLM patients. RESULTS: T score positively correlated with superior prognosis, while P score negatively associated with poor survival (all p<0.05). Meanwhile, T score was positively associated with specific mutation subtype of KRAS. Furthermore, TLSs enrichment gene expression was significantly associated with survival and transcriptomic subtypes of CRCLM. Subsequently, mIHC showed that the densities of Treg cells, M2 macrophages and Tfh cells were significantly higher in intratumor TLSs than in peritumor TLSs (p=0.029, p=0.047 and p=0.041, respectively), and the frequencies of Treg cells and M2 macrophages were positively correlated with P score, while the frequencies of Tfh cells were positively associated with T scores in intratumor TLSs (all p<0.05). Next, based on the distribution and abundance of TLSs, an Immune Score combining T score and P score was established which categorized CRCLM patients into four immune classes with different prognosis (all p<0.05). Among them, patients with higher immune class have more favorable prognoses. The C-index of Immune Class for RFS and OS was higher than Clinical Risk Score statistically. These results were also confirmed by the other two validation cohorts. CONCLUSIONS: The distribution and abundance of TLSs is significantly associated with RFS and OS of CRCLM patients, and a novel immune class was proposed for predicting the prognosis of CRCLM patients.
format Online
Article
Text
id pubmed-9923349
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99233492023-02-14 Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases Zhang, Chong Wang, Xiang-Yu Zuo, Jie-Liang Wang, Xue-Fu Feng, Xiao-Wen Zhang, Bo Li, Yi-Tong Yi, Chen-He Zhang, Peng Ma, Xiao-Chen Chen, Zhen-Mei Ma, Yue Han, Jia-Hao Tao, Bao-Rui Zhang, Rui Wang, Tian-Qi Tong, Li Gu, Wang Wang, Si-Yu Zheng, Xiao-Fei Yuan, Wen-Kang Kan, Zi-Jie Fan, Jie Hu, Xiang-Yang Li, Jun Zhang, Chao Chen, Jin-Hong J Immunother Cancer Immunotherapy Biomarkers BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection from three cancer centers were included. The TLSs were categorized according to their anatomic subregions and quantified, and a TLS scoring system was established for intratumor region (T score) and peritumor region (P score). Differences in relapse-free survival (RFS) and overall survival (OS) between groups were determined. Multiplex immunohistochemical staining (mIHC) was used to determine the cellular composition of TLSs in 40 CRCLM patients. RESULTS: T score positively correlated with superior prognosis, while P score negatively associated with poor survival (all p<0.05). Meanwhile, T score was positively associated with specific mutation subtype of KRAS. Furthermore, TLSs enrichment gene expression was significantly associated with survival and transcriptomic subtypes of CRCLM. Subsequently, mIHC showed that the densities of Treg cells, M2 macrophages and Tfh cells were significantly higher in intratumor TLSs than in peritumor TLSs (p=0.029, p=0.047 and p=0.041, respectively), and the frequencies of Treg cells and M2 macrophages were positively correlated with P score, while the frequencies of Tfh cells were positively associated with T scores in intratumor TLSs (all p<0.05). Next, based on the distribution and abundance of TLSs, an Immune Score combining T score and P score was established which categorized CRCLM patients into four immune classes with different prognosis (all p<0.05). Among them, patients with higher immune class have more favorable prognoses. The C-index of Immune Class for RFS and OS was higher than Clinical Risk Score statistically. These results were also confirmed by the other two validation cohorts. CONCLUSIONS: The distribution and abundance of TLSs is significantly associated with RFS and OS of CRCLM patients, and a novel immune class was proposed for predicting the prognosis of CRCLM patients. BMJ Publishing Group 2023-02-09 /pmc/articles/PMC9923349/ /pubmed/36759015 http://dx.doi.org/10.1136/jitc-2022-006425 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Immunotherapy Biomarkers
Zhang, Chong
Wang, Xiang-Yu
Zuo, Jie-Liang
Wang, Xue-Fu
Feng, Xiao-Wen
Zhang, Bo
Li, Yi-Tong
Yi, Chen-He
Zhang, Peng
Ma, Xiao-Chen
Chen, Zhen-Mei
Ma, Yue
Han, Jia-Hao
Tao, Bao-Rui
Zhang, Rui
Wang, Tian-Qi
Tong, Li
Gu, Wang
Wang, Si-Yu
Zheng, Xiao-Fei
Yuan, Wen-Kang
Kan, Zi-Jie
Fan, Jie
Hu, Xiang-Yang
Li, Jun
Zhang, Chao
Chen, Jin-Hong
Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title_full Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title_fullStr Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title_full_unstemmed Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title_short Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
title_sort localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
topic Immunotherapy Biomarkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923349/
https://www.ncbi.nlm.nih.gov/pubmed/36759015
http://dx.doi.org/10.1136/jitc-2022-006425
work_keys_str_mv AT zhangchong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT wangxiangyu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zuojieliang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT wangxuefu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT fengxiaowen localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zhangbo localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT liyitong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT yichenhe localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zhangpeng localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT maxiaochen localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT chenzhenmei localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT mayue localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT hanjiahao localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT taobaorui localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zhangrui localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT wangtianqi localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT tongli localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT guwang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT wangsiyu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zhengxiaofei localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT yuanwenkang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT kanzijie localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT fanjie localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT huxiangyang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT lijun localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT zhangchao localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases
AT chenjinhong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases